Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700034403

Trial Profile

Clinical Trials Insight: 700034403

Phase of Trial: Phase I

Latest Information Update: 10 Jun 2010

At a glance

  • Drugs Zaleplon (Primary)
  • Indications Insomnia
  • Focus Pharmacokinetics
  • Sponsors SkyePharma PLC; Somnus Therapeutics
  • Most Recent Events

    • 10 Jun 2010 Results have been presented at the Association of Professional Sleep Societies 24th Annual Meeting, according to a Somnus Therapeutics media release. Results were discussed further in the media release.
    • 11 Dec 2008 Status changed from recruiting to completed.
    • 11 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top